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ReviewThe thymus is required for T cell differentiation; a pro-
cess that depends on which antigens are encountered by
thymocytes, the environment surrounding the differen-
tiating cells, and the thymic architecture. These features
are altered by local infection of the thymus and by the
inflammatory mediators that accompany systemic infec-
tion. Although once believed to be an immune privileged
site, it is now known that antimicrobial responses are
recruited to the thymus. Resolving infection in the thy-
mus is important because chronic persistence of
microbes impairs the differentiation of pathogen-specif-
ic T cells and diminishes resistance to infection. Under-
standing how these mechanisms contribute to disease
susceptibility, particularly in infants with developing T
cell repertoires, requires further investigation.
The thymus is essential for T cell differentiation
The appearance of adaptive immunity in jawed vertebrates
is considered a major evolutionary step, because B and T
cells enable the immune system to generate and recall
pathogen-specific immune responses [1]. Among lympho-
cytes, T cells are unique in their expression of the T cell
receptor (TCR). TCR-mediated recognition of microbial
peptides bound to major histocompatibility complex
(MHC) is the principle way that the immune system iden-
tifies infected cells. T cell precursors are generated in the
bone marrow and become functional after differentiation
within the thymus (Figure 1) [1]. The deceptively simple
anatomical structure of the thymus belies its sophisticated
ability to generate T cells expressing a broad TCR reper-
toire capable of recognizing virtually any foreign antigen.
Thymic selection eliminates most potentially harmful self-
reactive T cells. After selection, naı¨ve self-restricted T cells
exit the thymus and traffic to secondary lymphoid organs.
T cell differentiation depends on the thymic microenvi-
ronment and the cytokine milieu surrounding the differen-
tiating cells [1]. This raises the possibility that during
infection, changes in soluble factors or antigens present
within the thymus alter T cell differentiation. Indeed, sys-
temic infection has detrimental effects on thymic structure1471-4906/$ – see front matter
 2013 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.it.2013.06.004
Corresponding authors: Behar, S.M. (samuel.behar@umassmed.edu);
Correia-Neves, M. (mcorreianeves@ecsaude.uminho.pt).
Keywords: thymus; infection; T cell repertoire; antimicrobial response;
thymic microenvironment.and function (Figure 2). Furthermore, certain bacteria,
virus, fungi, and parasites can directly invade the thymus
(Table 1). These observations suggest that some pathogens,
particularly those that cause chronic infections, interfere
with the generation of immune responses designed to fight
them by disrupting T cell development and possibly altering
central tolerance. Here, we discuss how attitudes about
thymic function during infection are changing. It is now
clear that diverse pathogens infect the thymus, and because
of their local and systemic effects, disrupt its architecture
and function. We review recent evidence that the presence of
pathogens in the thymus leads to microbe-specific tolerance
and impairs host resistance. However, the immune system
reacts to such invasions by recruiting immune responses to
the thymus. Finally, we suggest that the ability to defend the
thymus from infection may be important in maintaining the
integrity of the immune system, particularly in situations
where the T cell repertoire is being generated or is regen-
erating, such as in young children or patients with AIDS,
respectively.
Thymus: myth and reality
Few studies have addressed whether infection affects thy-
mic function in people, with the exception of studies on HIV
infection [2]. In part, this is because of limited availability
of thymus from infected patients, because the thymus is
difficult to biopsy, and the usefulness of indirect measure-
ments of thymic activity in humans is still controversial. As
important are misconceptions that have affected how
scientists and physicians view thymic function. Although
now largely refuted, these include: (i) the thymus is an
immune-privileged site protected from infection and im-
mune responses; and (ii) thymic function is only important
during early life and dispensable after puberty.
The notion that the thymus is immune privileged is
inseparable from the concept of the blood–thymus barrier;
considered for several years to be responsible for an anti-
gen-free thymic microenvironment that prevents immune
responses to exogenous antigens [3]. However, it is now
clear that the thymus is both a target of infection and a site
to where immune responses are recruited (Table 1) [4–7].
Although the thymus is essential for the establishment of
a diverse T cell repertoire early in life, it is widely believed
to be unnecessary after puberty. This idea is supported by
the finding that the peripheral T cell pool can be maintained
by thymic-independent mechanisms [8]. Even if this wereTrends in Immunology xx (2013) 1–9 1
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Figure 1. T cell differentiation. Schematic representation of T cell traffic within the thymus and location of the major steps during T cell selection. T cell precursors from the
bone marrow enter the thymus in the cortico-medullary region and migrate to the cortex, where they go through the double negative (DN; e.g., CD4-CD8) stages of T cell
differentiation and become double positive (DP; e.g., CD4+CD8+) cells. DP cells migrate from the cortex to the medulla, interacting with structural components of the thymus
in these regions during positive and negative selection. The resulting naı¨ve single positive (SP; e.g., CD4+CD8 or CD4-CD8+) cells exit the thymus and migrate to the
peripheral lymphoid organs. Several microbes can be detected within the thymus following infection. Examples of microbes that are detected in the cortex, medulla or
cortico-medullary region of the thymus following in vivo infection are shown. Abbreviations: DC, dendritic cell; DN, double negative thymocytes; DP, double positive
thymocytes; SP, single positive thymocytes; cTEC, cortical thymic epithelial cell; mTEC, medullary thymic epithelial cell.
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infection on the thymus, because children and young adults
under the age of 24 years make up 44% of the world’s
population, and are particularly vulnerable to infection.
In 2011, nearly 6.9 million children under the age of 5 years
died, with infection causing more than half of these deaths
[9]. Although most of these deaths were due to acute infec-
tion (pneumonia, 14%; diarrhea, 10%; measles, 1%), a sig-
nificant number were due to chronic infection (malaria, 7%;
HIV/AIDS, 2%; tuberculosis, 1%) [9]. These numbers in-
crease with age and HIV/AIDS and tuberculosis account
for 11% of deaths among young adults (age 10–24 years)
worldwide [9]. Both HIV and Mycobacterium tuberculosis
infect the thymus and cause alterations in T cell output,
which could be relevant both in settings of vaccination and
during natural immunity to these pathogens [2,10–12].
Although childhood infections are arguably a greater
cause of morbidity and mortality than adult infection,
particularly in the developing world, recent studies rein-
force the idea that the thymus affects resistance to infec-
tion during adulthood. Reduced thymic output of T cells is
associated with HIV progression to AIDS and the thymus
has been implicated in the successful immune reconstitu-
tion of AIDS patients in response to antiretroviral therapy
[2]. Moreover, thymectomy during early childhood has
been linked to accelerated decline in immunologic function,2particularly following cytomegalovirus (CMV) infection
[13], and work on experimental viral infection models finds
that continuous recruitment of naı¨ve T cells from the
thymus has a beneficial role in the control of persistent
infections [14–16]. The integrity of the adult thymus is also
required for other aspects of ongoing immunity including
antibody generation [17] and oral tolerance [18]. These
observations indicate that an intact and functional thymus
is required for optimal immunity to infection throughout
life.
How does infection alter thymic function?
There are two ways in which infection can affect the
thymus: local and systemic (Figure 2). Local refers to
effects of direct infection of the thymus by microbes. Sys-
temic refers to the consequences of infection elsewhere on
the thymus. Systemic effects occur when soluble factors,
such as glucocorticoids (GCs) and proinflammatory med-
iators, are released into the blood stream.
Infection-induced thymic atrophy
Premature thymic atrophy is a common consequence of
infection by viruses, bacteria, parasites, and fungi (Box 1
and Figure 2) [19] and can result from local and/or systemic
effects. For example, GC levels rise during acute infection,
and can induce thymocyte apoptosis, especially among
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Figure 2. The effects of infection on the thymus. Schematic representation of how infection can affect the thymus through systemic and/or local effects. Glucocorticoids
and/or proinflammatory mediators mediate systemic effects, while local effects require the presence of a pathogen within the thymus. Infection-induced alterations include
thymic atrophy, modifications in the thymic structure, and alterations in the T cells exported to the periphery. Representative pathogens capable of inducing the different
alterations in thymic structure and/or function are indicated. Abbreviations: DN, double negative thymocytes; DP, double positive thymocytes.
Table 1. Pathogens that infect the thymusa.
Pathogen Consequences of infection Refs
Virus
HIV Atrophy [2,36–40]
Simian immunodeficiency virus (SIV) Atrophy (strain dependent) [30]
Influenza virus Atrophy (strain dependent); immune response in the thymus [7]
Lymphocytic choriomeningitis virus (LCMV) Atrophy; immune response in the thymus; pathogen-specific
immune tolerance
[6,62],
[63]
Murine leukemia virus (MLV) Atrophy; pathogen-specific immune tolerance [42,43,48]
Mouse hepatitis virus Atrophy [50]
Human cytomegalovirus (CMV) Atrophy [49]
Measles virus Atrophy (strain dependent); TEC apoptosis [29,51]
Coxsackievirus Modulation of TEC function [52]
Epstein–Barr virus (EBV) N/A [71]
Junin virus N/A [72]
Poliovirus N/A [73]
Bacteria
Mycobacterium avium Atrophy (strain dependent); immune response in the thymus;
pathogen-specific immune tolerance
[4,11],
[12,26]
Mycobacterium tuberculosis Immune response in the thymus [4,5,12]
Francisella tularensis Atrophy (strain dependent) [23]
Salmonella enterica Atrophy [60]
Fungi
Paracoccidioides brasiliensis Atrophy [74]
Cryptococcus neoformans Alterations in thymic architecture [75]
Parasites
Trypanosoma cruzi Atrophy (strain dependent); release of DP/DN/autoreactive
T cells; alterations in extracellular matrix
[24,46,47,67]
Plasmodium berghei Atrophy (strain dependent); release of DP/DN cells; alterations
in extracellular matrix
[44,45]
Toxoplasma gondii Atrophy [22]
aVirus, bacteria, fungi and parasites have been documented to infect the thymus, either in humans or experimental animal models. The major consequences of each
infection on thymic structure or function are listed, when information is available.
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Box 1. Mechanisms of thymic atrophy
Thymic involution is a physiological process that occurs naturally
and progressively with aging and also transiently during pregnancy
and stress. Atrophy occurs by a gradual and progressive decline in
the number of thymocytes, and known mechanisms of physiological
atrophy are mediated by either TEC or thymocytes (reviewed by
Dooley et al. [20]). Because interactions between developing
thymocytes and structural components of the thymus are essential
for normal T cell differentiation, alterations in TEC can result in
diminished functional thymopoiesis and export of naı¨ve T cells,
leading to thymic atrophy. For example, thymic atrophy depends on
sex hormones in a process that requires the expression of the
androgen/estrogen receptors by TEC. By contrast, thymocyte-
mediated atrophy is usually the result of alterations in the thymic
milieu that induce rapid apoptotic cell death of double positive (DP)
thymocytes. This is best exemplified by stress-mediated thymic
involution, which occurs by DP thymocyte death in response to
elevated levels of circulating GCs.
Several non-physiological stimuli can induce premature thymic
atrophy, such as infection. Infection-induced atrophy could occur
by: alterations in TECs; induction of apoptosis in thymocytes
particularly DP cells; or reduction of thymocyte precursors within
the bone marrow. The similarities between the mediators of
physiological and infection-induced thymic atrophy suggest that
the molecular mechanisms responsible for the decline in thymic
cellularity might be common in both settings, and this possibility
should be addressed experimentally (Box 2).
Why thymic atrophy should accompany infection is debated. The
different hypotheses include: (i) thymic atrophy is a by-product of
infection, with no specific advantage for the pathogen or the host;
(ii) thymic atrophy is a virulence strategy employed by pathogens to
subvert antimicrobial immunity; and (iii) thymic atrophy is a host
strategy that reduces thymic activity during infection to prevent
disruption of T cell selection and prevent the emergence of central
tolerance to the invading organism. In any case, thymic atrophy can
impair thymic function and has implications for ongoing immunity.
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to infection prevents thymocyte depletion in rabies virus
infected mice, which confirms a role for GCs in infection-
induced thymic atrophy [21]. Infection-induced premature
thymic atrophy also occurs independently of increased
systemic GC levels. For example, adrenalectomy prior to
Toxoplasma gondii infection abolishes peripheral lympho-
penia but does not prevent thymocyte loss [22]. In some
infections, GCs synergize with other mediators to induce
thymic atrophy. These include tumor necrosis factor (TNF)
during Francisella tularensis [23] and Trypanosoma cruzi
[24] infection, interferon (IFN)g during Salmonella enter-
ica infection [25], and IFNg and nitric oxide during Myco-
bacterium avium infection [26]. Moreover, some of these
molecules can alter thymic populations independently of
GCs. This is the case for TNF, which can lead to the
deletion of DP thymocytes, mediated by excessive periph-
eral T cell activation following antigen injection, even after
treatment with antagonists of GC receptors [27].
Interestingly, infection-induced thymic atrophy often
correlates with strain virulence, as observed for T. cruzi
[28], F. tularensis [23], M. avium [26], measles virus [29],
highly pathogenic avian influenza viruses (HPAIVs) [7],
and simian immunodeficiency virus (SIV) [30]. These data
suggest that specific microbial factors directly promote
thymocyte death. This is true for bacterial factors such
as lipopolysaccharide [31], Escherichia coli enterotoxin
[32], and mycobacterial cord factor [33], and has been
confirmed with the fungal virulence factors gliotoxin [34]4and toxin T-2 [35]; all of which directly induce thymocyte
apoptosis when administered to mice. Local thymic effects
are also observed after HIV infection [2]. HIV thymotropic
viral variants are detected in vivo [36], raising the possi-
bility that these strains would be more likely to affect
thymic function. The infected cell type depends on viral
tropism for chemokine CXC receptor (CXCR)4 and chemo-
kine CC receptor (CCR)5, but most thymocyte subsets can
become infected [2]. HIV also infects different thymic
stromal cells, including macrophages, conventional den-
dritic cells (cDCs), plasmacytoid DCs (pDCs), and thymic
epithelial cells (TECs) [37–39]. HIV affects the fate of
infected cell types differently. For example, CD4 single
positive (SP) thymocyte depletion results from direct in-
fection, killing of progenitor cells, and apoptosis induction
of uninfected cells by viral products [40]. HIV infection also
induces DC and TEC death [37,39]. In the case of DCs, cell
death is associated with IFNa production by pDCs but not
cDCs [37]. Thus, in addition to inducing thymocyte death,
HIV disrupts thymic function by altering the local micro-
environment. Collectively, these data show that HIV in-
fection induces thymic atrophy and impacts thymic
function, leading to a decline in the export of newly differ-
entiated T cells [2,41].
Similar to HIV, murine leukemia virus (MLV) has
specific long terminal repeat region sequences that affect
viral infection and replication in DP and double negative
(DN) thymocytes and in other thymic populations [42].
MLV induces apoptosis of infected cells within the thymus
even before the leukemic period. Apoptosis is induced by
the accumulation of Env protein precursors, triggering
endoplasmic reticulum stress [43]. Thus, apoptosis is a
consequence of local infection, and infected DP thymocytes
die more than uninfected cells within the thymus.
Thymic atrophy is also detected during infection of mice
with HPAIV [7]. These viruses cause severe human disease
accompanied by profound lymphopenia. After intranasal
challenge of mice, influenza-infected DCs are present in
the corticomedullary region of the thymus. Thymic atrophy
is strain dependent and occurs only after infection with
highly pathogenic virus. HPAIV interferes with thymic
function, inducing loss of DP thymocytes and diminished
export of naı¨ve T cells to the periphery, leading to severe
lymphopenia. It is unknown what role GCs play during this
acute infection and the relative contribution of local versus
systemic factors to thymic atrophy cannot be ascertained.
These studies demonstrate that local and systemic
effects can induce thymic atrophy during infection, and
are not mutually exclusive.
Thymic structure is altered by infection
Infection induces thymic structural alterations other than
atrophy (Figure 2). For example, both T. cruzi and Plasmo-
dium berghei directly infect the thymus and induce signifi-
cant changes in the extracellular matrix [19,28,44–46].
T. cruzi increases fibronectin and laminin deposition and
chemokine CXC ligand (CXCL)12 and chemokine CC ligand
(CCL)4 production within the thymus [46,47]. During
T. cruzi infection, expression of the fibronectin and laminin
receptors [very late antigen (VLA)-4, VLA-5 and VLA-6] and
CXCR4 and CCR5 is augmented on thymocytes and
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[46,47]. P. berghei affects thymocyte migration by inducing
CXCL12 and CXCR4 and reducing CCL25 and CCR9 pro-
duction within the thymus [45]. When analyzed ex vivo, both
DN and SP cells from infected thymi migrate faster than
control populations towards extracellular matrix compo-
nents [45]. In both cases, these changes affect peripheral
T cell subsets. At the peak of T. cruzi infection, a higher
frequency of immature and VLAhiDP T cells are found in the
periphery [46]. Similarly, increased numbers of DN and DP
T cells are found in the periphery of P. berghei-infected mice
[44].
Viral infections also induce significant changes in thymic
structure by infecting stromal cells. HIV can infect TECs in
vivo and lead to degeneration of these cells [39]. In vivo
infection of TECs has also been described using MLV [48]
and CMV [49]. Mouse hepatitis virus (MHV) [50], measles
virus [51], and type-B coxsackievirus [52] have been shown
to infect TECs in vitro. Interestingly, in vitro infection of
human TECs with measles virus results in terminal differ-
entiation and apoptosis of these cells [51]. By contrast, type-
B coxsackievirus infection of human TECs in vitro does not
cause damage but modulates cell function, leading to in-
creased production of interleukin (IL)-6, granulocyte–mac-
rophage colony-stimulating factor (GM-CSF), and leukocyte
migration inhibition factor (LIF) [52]. The observation that
viruses infect TECs, alter their function, and in some cases
induce cell death, is especially important given the crucial
role these cells play in T cell differentiation [53]. Finally, the
changes in thymic cellularity observed during viral infec-
tion may be caused by depletion of TECs and secondary
decline in thymocyte number.
These data show that structural alterations of the thy-
mus caused by infection modify the characteristics of dif-
ferentiating T cells and affect T cell export.
Alterations in thymic export
The appearance of DP thymocytes in the periphery, as
described following T. cruzi and P. berghei infection, is also
a hallmark of infections caused by HIV, hepatitis B virus
(HBV), and hepatitis C virus (HCV) [54,55]. MHV can be
detected within the thymus [56] (Table 1), and although
the origin of peripheral DP cells is unknown, one possibili-
ty is that they are released from the thymus due to local
infection (Figure 2). Alternately, activated T cells may
acquire a DP phenotype as observed during HIV and other
infections [57]. Whether peripheral DP cells are an indica-
tion of altered thymic function or whether they represent
activated T cells likely varies according to the infecting
agent and requires experimental investigation.
Alterations in thymic structure due to infection can alter
T cell export in other ways. A major consequence of HIV
infection is reduced export of recent thymic emigrants; an
effect confirmed by T cell rearrangement excision circle
(TREC) analysis [2,41]. As thymic activity is essential to
maintain or reconstitute a functional peripheral T cell pool,
interventions that enhance this process may potentiate the
beneficial effects of antiretroviral therapy on immunity [58].
Antigen-driven responses in the thymus can also sup-
press T cell export. Although not formally demonstrated
in the context of infection, intravenous or intrathymicinjection of foreign antigen leads to a significant reduc-
tion in the amount of recent thymic emigrants in the
periphery [59]. This is not due to increased negative
selection of developing thymocytes, but rather from re-
tention of medullary thymocytes within the thymus [59].
Although it is intuitive that reduced thymic T cell export
is a consequence of infection-induced thymic atrophy, this is
not always the case. During Salmonella-induced thymic
atrophy, T cell export is maintained [60], suggesting that
atrophy and a decline in thymic function might be indepen-
dent. Nevertheless, maintaining thymic export of recent
thymic emigrants during infectious episodes is important,
because it positively impacts ongoing immunity [14–18].
Generation of T cells tolerant to pathogens
Infection alters thymic structure and affects export of
immature and naı¨ve T cells. Another important question
is whether infection of the thymus and the presence of
microbial antigens in the thymus, particularly during
persistent infection, leads to pathogen-specific tolerance
(Figure 2). This question was investigated using a model of
mycobacterial infection. Infection of mice with M. avium of
intermediate virulence leads to chronic persistent infec-
tion. During this infection, M. avium disseminates to, and
persists in, the medulla and corticomedullary region of the
thymus [11,12]. No thymic atrophy occurs and the chroni-
cally infected thymus continues to support T cell differen-
tiation. However, T cells that mature within infected thymi
are abnormal because they suboptimally respond to
M. avium antigens compared to T cells that differentiate
in uninfected thymi. Importantly, T cells that differentiate
in M. avium-infected thymi respond normally to unrelated
antigens, indicating that the defect is specific for the
invading pathogen [11]. Although the precise mechanisms
responsible for this difference is still being elucidated
(Box 2), these data demonstrate that thymic infection
can induce pathogen-specific T cell tolerance.
Whether tolerance also emerges in the setting of chronic
M. tuberculosis infection is a matter of debate. At various
times after M. tuberculosis infection, Reiley et al. treated
mice with the myeloablative drug busulfan and then infused
bone marrow from ESAT6-specific TCR transgenic mice [5].
ESAT6 is a protein secreted by M. tuberculosis and is an
immunodominant antigen recognized by human and mu-
rine T cells. This established mixed bone marrow chimeras
containing a population of congenically marked ESAT6-
specific naı¨ve CD4+ T cells. When performed 30 days after
infection, a significant population of congenic ESAT6-spe-
cific CD4+ T cells appeared in lungs within 49 days after
reconstitution and gradually increased during the next 3
months. However, if the bone marrow infusion was delayed
until 3 months after infection, few if any ESAT6-specific
CD4+ T cells could be detected in the lung 49 and 63 days
after reconstitution, and only began to appear 84 days after
infection, reaching steady-state levels by 140 days. This
result was interpreted as indicating that recent thymic
emigrants help maintain the peripheral T cell response to
M. tuberculosis; central tolerance to M. tuberculosis anti-
gens does not occur. The authors suggested that the decline
in the expansion of congenic recent thymic emigrants after
day 90 was due to diminished priming and/or expansion of5
Box 2. Outstanding questions
 How universal is thymic infection? Do other pathogens infect the
thymus?
 How does the thymus get infected? Do pathogens directly target
the thymus, or do they disseminate inside recirculating cells?
 Why does atrophy accompany thymic infection so frequently? Is
atrophy beneficial for the host or the bug? What are the
mechanisms responsible for infection-induced thymic atrophy?
 What are the mechanisms responsible for T cell tolerance? Does
the presence of microbial antigens lead to negative selection of
developing T cells? Do microbe-specific regulatory T cells emerge
following thymic infection? Are developing T cells anergic to the
infectious agent?
 How does infection of the thymus impact ongoing immunity?
Does thymic infection during childhood impact immunity later in
life? Is thymic infection relevant during vaccination with live
microorganisms?
 How important are newly generated T cells during chronic
infections and during immune reconstitution?
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tive interpretation of their data is that M. tuberculosis
colonization of the thymus leads to tolerance. Few bacteria
are present in the thymus during the first month after
infection; by contrast, nearly all infected mice have a signif-
icant bacterial load by 3 months [4,5,12]. The diminished
expansion of primed ESAT6-specific CD4+ T cells late after
infection (d90) can be explained by the progressive develop-
ment of tolerance during chronic mycobacterial infection,
which occurs only when there is a significant amount of
mycobacterial antigen in the thymus. Clearly, whether
infection-induced central tolerance contributes to the inabil-
ity of recent thymic emigrants to integrate the immune
response during chronic infection with M. tuberculosis
requires further investigation.
Tolerance to invading pathogens is also observed during
viral infection. Neonatal MLV infection leads to infection of
thymocytes as well as thymic stromal cells, and renders T
cells tolerant to viral antigens [61]. Similarly, congenitally
acquired lymphocytic choriomeningitis virus (LCMV) in-
fection is a model of immune tolerance: mice infected in
utero or at birth show high viral titers in most organs,
including the thymus, and have a selective defect in
LCMV-specific T cell immunity [62]. LCMV infection of
the thymus starts at the fetal stage in DN cells, and
transitions to CD4 SP cells in the adult thymus. By con-
trast, CD8+ T cell infection is minimal [63], and transferred
virus-specific cytotoxic T lymphocytes (CTLs), from immu-
nized mice, infiltrate the thymus and eliminate the infec-
tion [6,62]. In this model, viral clearance is associated with
reacquisition of LCMV-specific CTL responses, suggesting
that continuous presence of the antigen in the thymus is
required to maintain tolerance, not only during fetal de-
velopment but in adult animals as well.
Viral hepatitis also induces central tolerance to HBV.
Although acute infection in adults is readily resolved, HBV
infection in utero induces tolerance to viral proteins [64], and
infants born to HBV-infected mothers are more likely to
become chronic carriers of HBV [65]. One possibility is that
viral proteins in the neonatal thymus induce HBV-specific T
cell tolerance. This hypothesis is supported by the observa-
tion that both MLV and HBV infect TECs [50,61], which
could explain why these infections induce T cell tolerance
while others do not. TEC turnover is rapid [66], therefore,
this hypothesis implies that these viruses can continually
infect new TECs or reside in thymic epithelial stem cells.
These data suggest that direct infection of the thymus
by viruses and bacteria alter T cell selection and induce
tolerance against the invading pathogen, with the poten-
tial to impair ongoing immunity. An interesting question is
whether the mechanism of tolerance induced by thymic
infection involves the generation of pathogen-specific reg-
ulatory T cells, T cell anergy, or negative selection of
differentiating pathogen-reactive T cells (Box 2).
Autoimmunity induced by thymic infection
Pathogens that disrupt thymic function may also disrupt
the development of central tolerance. Autoreactive T cells
that are normally negatively selected in the thymus might
escape death because of thymic dysfunction, emigrate to
the periphery, and trigger autoimmunity. Although this6possibility remains theoretical, some data support it. Dur-
ing experimental T. cruzi infection, T cells expressing
‘forbidden’ TCRs that are normally deleted in the thymus,
particularly those belonging to the Vb5 and Vb12 families,
survive and can be detected in peripheral lymph nodes [67].
Thymic SP cells from infected mice are not enriched in
those TCRs. These data indicate that the appearance of
these forbidden TCRs in the periphery is not due to defec-
tive negative selection but a consequence of abnormal
migration of immature cells [67]. In addition, anti-thymus
antibodies and myocardium-specific autoreactive T cells
are detected following T. cruzi infection [28], raising the
possibility that infection-induced thymic alterations poten-
tiate autoimmunity.
Thymic infection: the beginning and the end
How are various microbes able to reach the thymus and
establish infection? Furthermore, if dissemination to the
thymus occurs commonly during infection, has the immune
system evolved mechanisms to respond to pathogens in-
vading the thymus?
How do microorganisms reach the thymus?
Two scenarios are possible when considering the origin of
thymic infection during hematogenous spread of infection
(Figure 3; Box 2). First, circulating pathogens can enter the
thymus and infect cells in a targeted manner, as repre-
sented by thymotropic variants of HIV [36] and MLV [42].
Alternately, there is the ‘Trojan Horse’ model. The traf-
ficking of several cell types between the periphery and the
thymus make this possible. T cells circulate from the
periphery to the thymus [68], and if infected, could seed
the thymus with pathogens that target T cells (e.g., HIV).
Similarly, certain DC subsets (e.g., Sirpa+ cDCs) migrate
from the periphery to the thymus and modulate T cell
tolerance [69]. DCs infected with influenza virus or M.
avium can be detected within the thymus, raising the
possibility that infected DCs spread the infection [7,11].
DCs are responsible for disseminating M. tuberculosis from
the lung to the draining lymph nodes [70], and it is possible
that dissemination to the thymus occurs by a similar
mechanism. Together, these data support the idea that
cells circulating to the thymus can carry infectious agents
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Figure 3. Immune response in the thymus. Schematic representation of microbial dissemination and recruitment of an immune response to the thymus. Under normal
conditions, mature T cells and DC circulate from peripheral lymphoid organs to the thymus (left panel). Following infection, pathogens disseminate from the periphery to
the thymus, either extracellularly or within re-circulating cells. The infected thymus produces chemokines, such as CXCL9 and CXCL10, which recruit CXCR3-expressing
antigen-specific T cells from the peripheral tissues back to the thymus to fight infection (right panel). Abbreviation: LN, lymph node.
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lary is that the route and duration of infection may modify
the risk that the thymus becomes infected by different
pathogens.
Immunity within the thymus
If the thymus is a site of infection, it may recruit an
immune response against invading pathogens. As dis-
cussed, during systemic LCMV infection, LCMV-specific
CTLs traffic to the thymus, establish an immune response,
and eliminate LCMV from the thymus [6,62]. Similarly,
during influenza infection, functional influenza-specific
CTLs are detected within the thymus [7]. Finally, anti-
gen-specific CD4+ and CD8+ T cells are detected in the
thymus following M. avium and M. tuberculosis infection,
as part of the immune response against persistent bacteria
[4,5]. The responding T cells in the thymus are not newly
differentiated mature thymocytes but instead are activat-
ed T cells that circulate from peripheral organs to the
thymus to fight infection (Figure 3) [4]. Under these con-
ditions, the recruitment of activated T cells is associated
with increased expression of T helper 1 chemokines and an
enrichment of CXCR3+mycobacteria-specific T cells within
the thymus [4]. These results confirm that the thymus is
not only a site of infection, but suggest that it is actively
surveyed by the immune system.
Concluding remarks
The recent studies reviewed here show that the thymus is a
site of infection that has important immunological conse-
quences. Pathogens disrupt thymic structure and function,
and alter T cell selection and export. These changes affect
the peripheral T cell pool and affect ongoing and future
immune responses.
These data suggest a model in which the effect of infec-
tion on the thymus depends on the type of microbe, theseverity of infection, and the ability of the pathogen to
infect and persist within the infected thymus (Figure 2). In
this scheme, acute infection is characterized by increased
GCs and proinflammatory mediator levels, which can lead
to thymic atrophy. This effect is more pronounced in DP
cells and can occur even in the absence of the pathogen in
the thymus. Local thymic infection can exacerbate atrophy,
through remodeling of extracellular matrix, production of
virulence factors, or direct infection of thymic cells. These
structural changes affect thymic function; particularly T
cell export, leading to the release of immature (DP/DN) or
autoreactive T cells into the periphery. Despite the pro-
found effects of acute infection on the thymus, the impact of
thymic dysfunction on immunity is predicted to be limited
and transient because the peripheral T cell pool should
include pre-existing pathogen-specific T cells. By contrast,
local thymic infection may have severe repercussions,
particularly for: (i) infections acquired during childhood
– when the T cell repertoire is still developing; (ii) in the
setting of persistent infection (e.g., tuberculosis), which
may induce T cell tolerance; and (iii) infections associated
with severe lymphopenia (e.g., HIV), when lymphoid re-
constitution is required. In these cases, emergence of
central tolerance to the infectious agent may impair
deployment of pathogen-reactive T cells in the naı¨ve rep-
ertoire. Such a scenario could favor the microbe, because
impairment of T cell immunity would contribute to patho-
gen persistence. In order to minimize such consequences,
mechanisms exist to respond to direct infection of the
thymus (Figure 3). Just as in other tissues, these rely on
the trafficking of peripheral T cells from secondary lym-
phoid tissue back to the thymus. Although required for
protection, circulation of cells back to the thymus could
allow some pathogens access to the thymus.
Altogether, preserving a sterile thymic environment is
important to maintain thymic integrity, both structurally7
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export, and prevent the emergence of tolerance to invading
pathogens. Therefore, the thymus should be regarded as an
active player during infectious episodes and the contribu-
tion of this organ for ongoing immunity should be
addressed in future studies (Box 2).
Acknowledgments
We thank Joana Neves and Nadine Santos for critical reading of the
manuscript. This work was supported by Portuguese Foundation for
Science and Technology (FCT) grant PTDC/SAU-MII/101663/2008 and
individual fellowships to CN-A and CN. SMB was supported by National
Institutes of Health Grant R01 R56 AI067731.
References
1 Starr, T.K. et al. (2003) Positive and negative selection of T cells. Annu.
Rev. Immunol. 21, 139–176
2 Ho Tsong Fang, R. et al. (2008) The role of the thymus in HIV infection:
a 10 year perspective. AIDS 22, 171–184
3 Raviola, E. and Karnovsky, M.J. (1972) Evidence for a blood-thymus
barrier using electron-opaque tracers. J. Exp. Med. 136, 466–498
4 Nobrega, C. et al. (2013) T cells home to the thymus and control
infection. J. Immunol. 190, 1646–1658
5 Reiley, W.W. et al. (2012) Maintenance of peripheral T cell responses
during Mycobacterium tuberculosis infection. J. Immunol. 189, 4451–
4458
6 Gossmann, J. et al. (1991) Entry of antivirally active T lymphocytes into
the thymus of virus-infected mice. J. Immunol. 146, 293–297
7 Vogel, A.B. et al. (2010) Highly pathogenic influenza virus infection of
the thymus interferes with T lymphocyte development. J. Immunol.
185, 4824–4834
8 Freitas, A.A. and Rocha, B.B. (1993) Lymphocyte lifespans:
homeostasis, selection and competition. Immunol. Today 14, 25–29
9 World Health Organization (2013) Global health observatory. http://
www.who.int/gho/child_health/en/
10 Prabhu, A.D. et al. (2008) Tuberculosis of thymus – a case report. Heart
Lung Circ. 17, 345–346
11 Nobrega, C. et al. (2010) Dissemination of mycobacteria to the thymus
renders newly generated T cells tolerant to the invading pathogen. J.
Immunol. 184, 351–358
12 Nobrega, C. et al. (2007) The thymus as a target for mycobacterial
infections. Microbes Infect. 9, 1521–1529
13 Sauce, D. et al. (2009) Evidence of premature immune aging in patients
thymectomized during early childhood. J. Clin. Invest. 119, 3070–3078
14 Vezys, V. et al. (2006) Continuous recruitment of naive T cells
contributes to heterogeneity of antiviral CD8 T cells during
persistent infection. J. Exp. Med. 203, 2263–2269
15 Miller, N.E. et al. (2005) Role of thymic output in regulating CD8 T-cell
homeostasis during acute and chronic viral infection. J. Virol. 79,
9419–9429
16 Pellegrini, M. et al. (2011) IL-7 engages multiple mechanisms to
overcome chronic viral infection and limit organ pathology. Cell 144,
601–613
17 AbuAttieh, M. et al. (2012) Affinity maturation of antibodies requires
integrity of the adult thymus. Eur. J. Immunol. 42, 500–510
18 Song, F. et al. (2006) The thymus plays a role in oral tolerance in
experimental autoimmune encephalomyelitis. J. Immunol. 177, 1500–
1509
19 Savino, W. (2006) The thymus is a common target organ in infectious
diseases. PLoS Pathog. 2, e62
20 Dooley, J. and Liston, A. (2012) Molecular control over thymic
involution: from cytokines and microRNA to aging and adipose
tissue. Eur. J. Immunol. 42, 1073–1079
21 Cardenas Palomo, L.F. et al. (1995) Lymphocyte subsets and cell
proliferation analysis in rabies-infected mice. J. Clin. Lab. Immunol.
46, 49–61
22 Huldt, G. et al. (1973) Effect of Toxoplasma gondii on the thymus.
Nature 244, 301–303
23 Chen, W. et al. (2005) Low dose aerosol infection of mice with virulent
type A Francisella tularensis induces severe thymus atrophy and
CD4+CD8+ thymocyte depletion. Microb. Pathog. 39, 189–196824 Perez, A.R. et al. (2007) Thymus atrophy during Trypanosoma cruzi
infection is caused by an immuno-endocrine imbalance. Brain Behav.
Immun. 21, 890–900
25 Deobagkar-Lele, M. et al. (2012) Interferon gamma and glucocorticoid
mediated pathways synergize to enhance death of CD4(+) CD8(+)
thymocytes during Salmonella enterica serovar Typhimurium
infection. Immunology 138, 307–321
26 Borges, M. et al. (2012) Molecular and cellular mechanisms of
Mycobacterium avium-induced thymic atrophy. J. Immunol. 189,
3600–3608
27 Martin, S. and Bevan, M.J. (1997) Antigen-specific and nonspecific
deletion of immature cortical thymocytes caused by antigen injection.
Eur. J. Immunol. 27, 2726–2736
28 Savino, W. et al. (1989) Studies on the thymus in Chagas’ disease. I.
Changes in the thymic microenvironment in mice acutely infected with
Trypanosoma cruzi. Eur. J. Immunol. 19, 1727–1733
29 Auwaerter, P.G. et al. (1996) Measles virus infection of thymic
epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J.
Virol. 70, 3734–3740
30 Wykrzykowska, J.J. et al. (1998) Early regeneration of thymic
progenitors in rhesus macaques infected with simian
immunodeficiency virus. J. Exp. Med. 187, 1767–1778
31 Baroni, C.D. et al. (1976) Biological effects of Escherichia coli
lipopolysaccharide (LPS) in vivo. I. Selection in the mouse thymus
of killer and helper cells. Immunology 31, 217–224
32 Tsuji, T. et al. (2000) Induction of apoptosis in lymphoid tissues of mice
after intramuscular injection of enterotoxigenic Escherichia coli
enterotoxin. Immunobiology 201, 377–390
33 Ozeki, Y. et al. (1997) In vivo induction of apoptosis in the thymus by
administration of mycobacterial cord factor (trehalose 6,60-dimycolate).
Infect. Immun. 65, 1793–1799
34 Sutton, P. et al. (1994) In vivo immunosuppressive activity of gliotoxin,
a metabolite produced by human pathogenic fungi. Infect. Immun. 62,
1192–1198
35 Islam, Z. et al. (1998) T-2 toxin induces thymic apoptosis in vivo in mice.
Toxicol. Appl. Pharmacol. 148, 205–214
36 Calabro, M.L. et al. (1995) HIV-1 infection of the thymus: evidence for a
cytopathic and thymotropic viral variant in vivo. AIDS Res. Hum.
Retroviruses 11, 11–19
37 Schmitt, N. et al. (2006) Differential susceptibility of human thymic
dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 20, 533–542
38 Rozmyslowicz, T. et al. (2010) HIV-1 infection inhibits cytokine
production in human thymic macrophages. Exp. Hematol. 38, 1157–1166
39 Stanley, S.K. et al. (1993) Human immunodeficiency virus infection of
the human thymus and disruption of the thymic microenvironment in
the SCID-hu mouse. J. Exp. Med. 178, 1151–1163
40 Su, L. et al. (1995) HIV-1-induced thymocyte depletion is associated
with indirect cytopathogenicity and infection of progenitor cells in vivo.
Immunity 2, 25–36
41 Douek, D.C. et al. (2001) Evidence for increased T cell turnover and
decreased thymic output in HIV infection. J. Immunol. 167, 6663–6668
42 Yoshimura, F.K. et al. (1999) Sequences between the enhancer and
promoter in the long terminal repeat affect murine leukemia virus
pathogenicity and replication in the thymus. J. Virol. 73, 4890–4898
43 Yoshimura, F.K. and Luo, X. (2007) Induction of endoplasmic
reticulum stress in thymic lymphocytes by the envelope precursor
polyprotein of a murine leukemia virus during the preleukemic
period. J. Virol. 81, 4374–4377
44 Francelin, C. et al. (2011) Effects of Plasmodium berghei on thymus: high
levels of apoptosis and premature egress of CD4(+)CD8(+) thymocytes in
experimentally infected mice. Immunobiology 216, 1148–1154
45 Gameiro, J. et al. (2010) Changes in cell migration-related molecules
expressed by thymic microenvironment during experimental
Plasmodium berghei infection: consequences on thymocyte
development. Immunology 129, 248–256
46 Cotta-de-Almeida, V. et al. (2003) Trypanosoma cruzi infection
modulates intrathymic contents of extracellular matrix ligands and
receptors and alters thymocyte migration. Eur. J. Immunol. 33, 2439–
2448
47 Mendes-da-Cruz, D.A. et al. (2006) Altered thymocyte migration during
experimental acute Trypanosoma cruzi infection: combined role of
fibronectin and the chemokines CXCL12 and CCL4. Eur. J.
Immunol. 36, 1486–1493
Review Trends in Immunology xxx xxxx, Vol. xxx, No. x
TREIMM-1041; No. of Pages 948 Feldman, D.G. et al. (1967) Electron microscopic study of the mouse
leukemia virus (Gross) in organs of mouse embryos from virus-injected
and normal C3Hf parents. Cancer Res. 27, 1792–1804
49 Mocarski, E.S. et al. (1993) Human cytomegalovirus in a SCID-hu
mouse: thymic epithelial cells are prominent targets of viral
replication. Proc. Natl. Acad. Sci. U.S.A. 90, 104–108
50 Lamontagne, L. and Jolicoeur, P. (1994) Low-virulent mouse hepatitis
viruses exhibiting various tropisms in macrophages, T and B cell
subpopulations, and thymic stromal cells. Lab. Anim. Sci. 44, 17–24
51 Valentin, H. et al. (1999) Measles virus infection induces terminal
differentiation of human thymic epithelial cells. J. Virol. 73, 2212–2221
52 Brilot, F. et al. (2002) Persistent infection of human thymic epithelial
cells by coxsackievirus B4. J. Virol. 76, 5260–5265
53 Takahama, Y. (2006) Journey through the thymus: stromal guides for
T-cell development and selection. Nat. Rev. Immunol. 6, 127–135
54 Weiss, L. et al. (1998) Persistent expansion, in a human
immunodeficiency virus-infected person, of V beta-restricted
CD4+CD8+ T lymphocytes that express cytotoxicity-associated
molecules and are committed to produce interferon-gamma and
tumor necrosis factor-alpha. J. Infect. Dis. 178, 1158–1162
55 Nascimbeni, M. et al. (2011) Distinct CD4+ CD8+ double-positive T
cells in the blood and liver of patients during chronic hepatitis B and C.
PLoS ONE 6, e20145
56 Godfraind, C. et al. (1995) Thymus involution induced by mouse
hepatitis virus A59 in BALB/c mice. J. Virol. 69, 6541–6547
57 Nascimbeni, M. et al. (2004) Peripheral CD4(+)CD8(+) T cells are
differentiated effector memory cells with antiviral functions. Blood
104, 478–486
58 Corbeau, P. and Reynes, J. (2011) Immune reconstitution under
antiretroviral therapy: the new challenge in HIV-1 infection. Blood
117, 5582–5590
59 Uldrich, A.P. et al. (2006) Antigen challenge inhibits thymic
emigration. J. Immunol. 176, 4553–4561
60 Ross, E.A. et al. (2012) Thymic function is maintained during
Salmonella-induced atrophy and recovery. J. Immunol. 189, 4266–4274
61 Korostoff, J.M. et al. (1990) Neonatal exposure to thymotropic gross
murine leukemia virus induces virus-specific immunologic
nonresponsiveness. J. Exp. Med. 172, 1765–177562 Jamieson, B.D. and Ahmed, R. (1988) T-cell tolerance: exposure to
virus in utero does not cause a permanent deletion of specific T cells.
Proc. Natl. Acad. Sci. U.S.A. 85, 2265–2268
63 Ahmed, R. et al. (1987) Virus-lymphocyte interaction: T cells of the
helper subset are infected with lymphocytic choriomeningitis virus
during persistent infection in vivo. J. Virol. 61, 1571–1576
64 Milich, D.R. et al. (1990) Is a function of the secreted hepatitis B e
antigen to induce immunologic tolerance in utero? Proc. Natl. Acad.
Sci. U.S.A. 87, 6599–6603
65 Stevens, C.E. et al. (1975) Vertical transmission of hepatitis B antigen
in Taiwan. N. Engl. J. Med. 292, 771–774
66 Gray, D.H. et al. (2006) Developmental kinetics, turnover, and
stimulatory capacity of thymic epithelial cells. Blood 108, 3777–3785
67 Mendes-da-Cruz, D.A. et al. (2003) Experimental Trypanosoma cruzi
infection alters the shaping of the central and peripheral T-cell
repertoire. Microbes Infect. 5, 825–832
68 Hale, J.S. and Fink, P.J. (2009) Back to the thymus: peripheral T cells
come home. Immunol. Cell Biol. 87, 58–64
69 Proietto, A.I. et al. (2009) The impact of circulating dendritic cells on
the development and differentiation of thymocytes. Immunol. Cell Biol.
87, 39–45
70 Wolf, A.J. et al. (2007) Mycobacterium tuberculosis infects dendritic
cells with high frequency and impairs their function in vivo. J.
Immunol. 179, 2509–2519
71 Cavalcante, P. et al. (2010) Epstein-Barr virus persistence and
reactivation in myasthenia gravis thymus. Ann. Neurol. 67, 726–738
72 Calello, M.A. et al. (1986) Relationship between Junin virus infection of
thymus and the establishment of persistence in rodents. Med.
Microbiol. Immunol. 175, 109–112
73 Cavalcante, P. et al. (2010) Detection of poliovirus-infected
macrophages in thymus of patients with myasthenia gravis.
Neurology 74, 1118–1126
74 Brito, V.N. et al. (2003) Thymus invasion and atrophy induced by
Paracoccidioides brasiliensis in BALB/c mice. Med. Mycol. 41, 83–87
75 Sotomayor, C.E. et al. (1995) Immunosuppression in experimental
cryptococcosis: variation of splenic and thymic populations and
expression of class II major histocompatibility complex gene
products. Clin. Immunol. Immunopathol. 77, 19–269
